Armata Pharmaceuticals (ARMP) EBT (2016 - 2018)
Historic EBT for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$1.1 million.
- Armata Pharmaceuticals' EBT rose 5318.88% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$9.4 million, marking a year-over-year increase of 3411.67%. This contributed to the annual value of -$53.2 million for FY2024, which is 2270.81% down from last year.
- Per Armata Pharmaceuticals' latest filing, its EBT stood at -$1.1 million for Q4 2018, which was up 5318.88% from -$2.8 million recorded in Q3 2018.
- Armata Pharmaceuticals' 5-year EBT high stood at -$779000.0 for Q3 2017, and its period low was -$11.3 million during Q1 2014.
- For the 5-year period, Armata Pharmaceuticals' EBT averaged around -$4.0 million, with its median value being -$2.9 million (2015).
- Its EBT has fluctuated over the past 5 years, first tumbled by 69125.26% in 2014, then skyrocketed by 7661.1% in 2017.
- Quarter analysis of 5 years shows Armata Pharmaceuticals' EBT stood at -$2.6 million in 2014, then fell by 13.21% to -$2.9 million in 2015, then tumbled by 242.04% to -$10.1 million in 2016, then skyrocketed by 76.61% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
- Its EBT was -$1.1 million in Q4 2018, compared to -$2.8 million in Q3 2018 and -$3.2 million in Q2 2018.